Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cytosorbents Corporation, 3 years.
Cytosorbents Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cytosorbents Corporation August 13, 202687.8%
-
Cytosorbents Corporation June 12, 202585.3%
-
Cytosorbents Corporation June 6, 202492.0%
-
Cytosorbents Corporation June 6, 202396.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Cytosorbents Corporation | Open-market purchase | +1,900 | $6.12 | $11,628 |
| Sep 15, 2026 | Cytosorbents Corporation | Open-market purchase | +500 | $6.05 | $3,025 |
| Sep 15, 2026 | Cytosorbents Corporation | Open-market purchase | +100 | $6.01 | $601 |
| Feb 24, 2025 | Cytosorbents Corporation | Out-of-the-money exercise | +21,950 | $1.13 | $24,804 |
| Jan 17, 2025 | Cytosorbents Corporation | In-the-money exercise | +21,950 | $1.00 | $21,950 |
| Dec 13, 2023 | Cytosorbents Corporation | Open-market purchase | +22,557 | $1.33 | $30,001 |
| Feb 27, 2023 | Cytosorbents Corporation | Gift | +2,000 | — | — |
| Feb 27, 2023 | Cytosorbents Corporation | Gift | −2,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.